Dr. Raman on Hematuria in Urothelial Cancer

Jay D. Raman, MD
Published: Monday, May 15, 2017



Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with urothelial carcinoma.

Every patient with micro- or macrohematuria has the concern that it could be caused from cancer. However, one of the challenges is determining which patients with hematuria have a significant cancer.

Cxbladder Resolve is a tool that helps better stratify those who are at a higher risk for more significant bladder cancer and get them checked in a more timely manner, explains Raman.
 


Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with urothelial carcinoma.

Every patient with micro- or macrohematuria has the concern that it could be caused from cancer. However, one of the challenges is determining which patients with hematuria have a significant cancer.

Cxbladder Resolve is a tool that helps better stratify those who are at a higher risk for more significant bladder cancer and get them checked in a more timely manner, explains Raman.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x